Forever, For A Price
THE WEEK|August 06, 2017

The immortality industry is booming, thanks to massive funding and extensive research.

Emily Hill
Forever, For A Price

Imagine a world in which you are 90 years old and nowhere near middle-aged. An app on your phone has hacked your DNA code, so you know exactly when to go to the doctor to receive gene therapy to prevent all the diseases you don’t yet have. Every evening you sync your brain-mapping device with the Cloud, so even if you had a fatal accident you would still be able to cheat death—every detail of your life would simply be downloaded to one of the perfect silicon versions you had made of yourself, ensuring you last until at least your 1,000th birthday.

This may sound like science fiction but it could be your fate, provided you can afford it. If current research develops into medicine, in the future the super-rich won’t simply be able to buy the best things in life, they will be able to buy life itself by transforming themselves into a bio-engineered super-race, capable of living, if not forever, then for vastly longer than the current life expectancy.

The science of turning back the clock has never been more advanced. In Boston, a drug capable of reversing half a lifetime of ageing in mice is about to be tested on humans in a medical trial monitored by NASA. NMN (nicotinamide mononucleotide) is a compound found naturally in broccoli that boosts levels of NAD (nicotinamide adenine dinucleotide), a protein involved in energy production that depletes as we get older. Professor David Sinclair, who headed the initial research at Australia’s University of New South Wales, doses himself with 500mg daily and claims that he has already become more youthful. According to blood tests analysing the state of the 48-year-old’s cells, prior to taking the pills Sinclair was in the same physical shape as a 57-year-old, but now he is “31.4”.

この記事は THE WEEK の August 06, 2017 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、8,500 以上の雑誌や新聞にアクセスしてください。

この記事は THE WEEK の August 06, 2017 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、8,500 以上の雑誌や新聞にアクセスしてください。

THE WEEKのその他の記事すべて表示
How Anger Can Hurt Your Heart
THE WEEK India

How Anger Can Hurt Your Heart

Getting angry can constrict blood vessels and increase a person's risk of developing heart in the Journal of the American Heart Association.

time-read
1 min  |
June 02, 2024
Winner in a wheelchair
THE WEEK India

Winner in a wheelchair

Cerebral palsy could not stop Sarika from achieving her dream of becoming a civil servant

time-read
3 分  |
June 02, 2024
BONE SUPREMACY
THE WEEK India

BONE SUPREMACY

Taking good care of your bones will take a big load off your old age

time-read
7 分  |
June 02, 2024
AT WHAT AGES DO PEOPLE FEEL MOST LONELY?
THE WEEK India

AT WHAT AGES DO PEOPLE FEEL MOST LONELY?

ACCORDING TO A US STUDY PUBLISHED in the journal Psychological Science, loneliness follows a U-shaped pattern in adulthood  people are loneliest during younger and older adulthood, and least lonely in middle age.

time-read
1 min  |
June 02, 2024
MAMMOGRAM RECOMMENDED FROM AGE 40
THE WEEK India

MAMMOGRAM RECOMMENDED FROM AGE 40

THE US PREVENTIVE SERVICES TASK FORCE (USPSTF) has issued new recommendations for all women to start getting mammograms every other year beginning at age 40 and continuing through age 74.

time-read
1 min  |
June 02, 2024
TREATING GUM DISEASE CAN HELP PREVENT AFib RECURRENCE
THE WEEK India

TREATING GUM DISEASE CAN HELP PREVENT AFib RECURRENCE

PATIENTS WHO HAD THEIR GUM DISEASE treated following treatment for atrial fibrillation (AFib), or irregular heartbeat, are significantly less likely to suffer AFib recurrence, according to Japanese research published in the Journal of the American Heart Association.

time-read
1 min  |
June 02, 2024
LIFT OR STAIRS? ALWAYS CHOOSE STAIRS
THE WEEK India

LIFT OR STAIRS? ALWAYS CHOOSE STAIRS

ACCORDING TO A STUDY PRESENTED AT ESC Preventive Cardiology 2024, climbing stairs is associated with a lower risk of cardiovascular disease and death.

time-read
1 min  |
June 02, 2024
ESKETAMINE INJECTION MAY REDUCE RISK OF POSTPARTUM DEPRESSION
THE WEEK India

ESKETAMINE INJECTION MAY REDUCE RISK OF POSTPARTUM DEPRESSION

A SINGLE LOW DOSE INJECTION of esketamine given right after childbirth can reduce the risk of major postpartum depression by about three quarters, finds a US study published in The BMJ.

time-read
1 min  |
June 02, 2024
Nancy, how about Kanhaiya?
THE WEEK India

Nancy, how about Kanhaiya?

I have been following Nancy Tyagi on Instagram for over a year.

time-read
2 分  |
June 02, 2024
Cannes can do
THE WEEK India

Cannes can do

Never mind that India is witnessing a massive general election, perhaps one of the dirtiest it has ever witnessed.

time-read
2 分  |
June 02, 2024